Search results
AstraZeneca withdraws Covid-19 vaccine citing low demand | CNN Business
CNN.com· 9 hours agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 2 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 6 days agoShould you invest $1,000 in Moderna right now? Before you buy stock in Moderna, consider...follow blueprint for success, including guidance on building...
Supreme Court rejected military chaplains' lawsuit saying their careers were ruined after refusing...
Business Insider· 7 days agoThe Supreme Court denied military chaplains' lawsuit claiming retaliation for refusing the COVID-19 ...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 6 days agoOn the stock market today, Moderna stock surged 12.7% to 125.59. Shares topped a...Beat During the...
Check Out What Whales Are Doing With MRNA - Moderna (NASDAQ:MRNA)
Benzinga· 1 day agoThe firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020 ...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 6 days agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Earnings call: Moderna reports a net loss of $12.2 billion By Investing.com
Investing.com· 6 days agoThe biotechnology company, known for its mRNA vaccine technology, highlighted its strategic...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 6 days agoModerna, Inc. price | Moderna, Inc. Quote Zacks Rank & Key Picks Moderna currently carries a Zacks...
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Digital Journal· 6 days agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula ...